Latest News

Bringing success to its clients is the prime focus of Aagami and it has brought another success to its Australian biotechnology client, Phosphagenics Limited (ASX: POH; OTCQX: PPGNY).

On 18 May, POH announced that it has expanded its existing agreement with Themis Medicare Limited, India, for its TPM®/Diclofenac gel, to include an additional 16 geographical markets.

Phosphagenics was advised on this licensing transaction by Aagami.

This is the 4th strategic partnership that Aagami has facilitated for POH, and looks forward to cementing further partnerships soon.

Aagami has signed up with another new client in the US. Client has a unique technology to delivery technology, which bypasses the Blood Brain Barrier (BBB) enabling drugs to reach the brain, hence enabling next-generation therapeutics for CNS disorders.

Read more...

Aagami CEO and Head – BD brought their Australian client CEO and VP in the holy week of March to India for high level and strategic meetings with Indian Pharma companies with whom advanced level discussions were in progress.

Read more...

A New York based plant biotech company has appointed Aagami to find licensing partners for their IP protected smoking cessation aid products.The client is poised to disrupt and penetrate the stale multi-billion dollar smoking cessation market with genetic engineering of the tobacco plant to decrease nicotine and other nicotinic alkaloids.

Read more...

It was a busy 2015 for Aagami with 5 deals for its various clients, several consulting assignments, few market intelligence assignments, a lot of travel within and outside US, and fortification of Aagami team with a partner level resource with global experience and expertise.

We are happy to share this roundup of the year gone by and looking forward to your continued support in 2016 and beyond. 

Highlights of 2015:

Client projects

We worked with new clients as well as got new assignments from existing /past clients. 

Strategic Consulting / Licensing / Partnering

  1. Out-Licensing of a Novel Anti-infective drug

    Partnership established for Canada. Term Sheet signed for US market.

  2. Establishing Distribution channel in India for a US based Labware Consumables Company

    Completed for South India and West India.

  3. Investment for development of therapies and vaccines of a oncology focused Louisiana Biotech Company 

    Facilitated Listing on OTC Markets using reverse merger resulting in Line of Credit (US$ 10mn).

  4. Out-licensing of Transdermal Drug Delivery Technology for a Public listed Company from Australia

    Several companies in advanced discussions including term sheet.

  5. Partnerships for a US client’s innovative technology for poorly soluble & heat-sensitive APIs

    Several companies in advanced discussions.

  6. Develop a 5 year strategy plan for a Natural Medicines & Herbal Ingredients company

    Started late 2015 and Ongoing.

  7. Licensing of Innovative vector tools to improve mammalian cell-based expression systems of a Norwegian company

    In discussions with several interested parties from India, Rest of Asia and Latin America.

Market Intelligence

  1. Market Study to Identify Acquisition Targets for a Global Leader in medical equipment and integrated solution for patients
  2. Competitive Landscape Assessment of Derma and Pain market for India Strategy of a technology development company of New Zealand
  3. Aagami Expert Speak: Great opportunity for India based Global companies: (Latin America on Sale:)
  4. Note on Mental Health (Especially Depression) in India (with facts and figures)
  5. A report on Select cross border deals in Life Sciences (2014-15) where Indian companies were involved ( Please feel free to ask for a complimentary copy).

Business development and networking

Jan 2015 – JP Morgan Healthcare and Biotech Showcase 2015 – 45+ meaningful meetings; enjoyed representing clients while also promoted Aagami services for New Business.

Jan 2015 – iBIO Co-founder and ‘Cures Within Reach’ Award winner Michael S Rosen joins Aagami as Partner Consultant.

Feb 2015 – Bangalore INDIA BIO 2015 – Represented several clients, got deals closed during the event, while also getting new business

March 2015 - Nutra India Summit – Represented a NZ PharmaNatural technology company 26 meetings to discuss licensing model while another 15 meetings to discuss Sales & Distribution model.

May 2015 - Aagami CEO and Partner Consultant made Presentation at Life Science Summit organised by Consulate General of India - Chicago.

June 2015 - BIO International Convention at Philadelphia; 50+ pre-arranged one on one business meetings for Aagami and its clients.

July 2015 - Dinesh Jain and Michael Rosen made presentations and co-chaired sessions at US-India Healthcare Summit in Minneapolis, Minnesota.

August 2015 - Business trip to India along with a New Zealand based Client for advanced discussions with the interested companies.

Nov 2015 – BIO Europe in Munich; 35+ pre-arranged business meetings with C level executives around the globe for Aagami and its clients.

Dec 2015 - Business Trip to India to represent a Texas based client. 10+ pre-arranged business meetings with C level executives in the Pharma industry.

We want to thank each of our business associates and friends like you, who have been with us all this while. Please accept our sincere gratitude as we look forward to working and sharing together again in 2016 and beyond.